参考文献/References:
[1]冯树芳,段兆珉,潘正娟,等.HR-HPV TCT检查联合阴道镜定位活组织病理检查在宫颈癌前病变及宫颈癌筛查中的价值[J].医学信息,2016,29(8):124-125. [2]李晓敏.宫颈细胞学检查结合阴道镜检查在宫颈癌筛查中的诊断价值[J].实用妇科内分泌电子杂志,2019,6(34):137. [3]潘翠笠,麦精达,崔色达,等.阴道镜检查在宫颈癌筛查中的价[J].海南医学,2017,28(16):2711-2712. [4]薄素焕,赵淑蕊.液基薄层细胞学检测联合阴道镜LEEP刀在宫颈癌筛查诊治中的应用[J].河北医药,2011,33(11):1644-1646. [5]郭方珍,陶柳,王克兵,等.宫颈癌筛查中阴道镜检查阳性与宫颈病理诊断关系的探讨[J].中国社区医师,2015,36(5):278,281. [6]张晶.HR-HPVTCT分别联合电子阴道镜下宫颈活组织病理检查在宫颈癌前病变及宫颈癌诊断的应用分析[J].中国医疗器械信息,2017,23(15):80-81. [7]柴东明,王征.宫颈癌筛查中阴道镜检查阳性与宫颈病理诊断关系的探讨[J].临床检验杂志(电子版),2019,8(2):170-171. [8]郑玉华.电子阴道镜与病理学检查早期诊断宫颈癌[J].中国基层医药,2004(11):51-52. [9]冯明月,闫萍.宫颈上皮内瘤变诊治现状[J].河北医科大学学报,2020,41(4):480-483. [10]王芳,李全荣,邱琳,等.宫颈高级别上皮内瘤变和宫颈癌患者的TCT和hrHPV结果分析[J].福建医科大学学报,2020,54(6):429-431. [11]易晓芳.宫颈肌瘤诊断与治疗的临床分析[J].中国医药指南,2010,8(6):89-90. [12]侯凤云,石倩茹,李海宁.TCT、HR-HPV检测联合阴道镜下定位活检在宫颈癌前病变筛查中的应用价值[J].宁夏医学杂志,2019,41(3):273-275. [13]于淼淼.宫颈细胞学联合阴道镜及Reid评分诊断宫颈癌前病变的临床价值[J].贵州医药,2016,40(11):1201-1203. [14]章文华,黄蔓妮,李淑梅,等.电子阴道镜与光学阴道镜在宫颈早期病变诊断中的比较研究[J].中华肿瘤杂志,2002,24(6):570,572. [15]梁月容,成燕萍,邵梅华.HPV,TCT筛查结合阴道镜下定位活检对筛查宫颈癌及癌前病变的作用分析[J].中国医药科学,2017,7(4):129-132. [16]言齐,黄文瑾,曾超益,等.HR-HPV、TCT分别联合电子阴道镜下宫颈活检在宫颈癌前病变及宫颈癌诊断中的应用[J].中国当代医药,2016(2):65-67. [17]王秋红,杜桂清,邓桂霞,等.HPV分型联合TCT检测及宫颈活检对宫颈癌癌前病变早期筛查的临床应用分析[J].北京医学,2016,38(1):72-73. [18]卢艳阳,王敬华.宫颈细胞学检查结合阴道镜检查在宫颈癌筛查中的诊断价值[J].中国妇幼保健,2015,30(28):4906-4907.
相似文献/References:
[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Medical Information,2018,31(15):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Medical Information,2018,31(15):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[3]蔡亚磊,邓思雨,杨 健.宫颈癌放疗增敏的研究现状[J].医学信息,2022,35(09):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
CAI Ya-lei,DENG Si-yu,YANG Jian.Research Status of Radiotherapy Sensitization for Cervical Cancer[J].Medical Information,2022,35(15):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
[4]车 莹.HPV感染与宫颈病变相关性的研究[J].医学信息,2022,35(09):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
CHE Ying.Study on the Correlation Between HPV Infection and Cervical Lesions[J].Medical Information,2022,35(15):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
[5]曹 亮,郝 朋,李阳明,等.宫颈癌所致输尿管梗阻患者输尿管支架置入成功率影响因素的Meta分析[J].医学信息,2022,35(09):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
CAO Liang,HAO Peng,LI Yang-ming,et al.Meta Analysis of Factors Influencing Success Rate of Ureteral Stent Implantation in Patients with Ureteral Obstruction Caused by Cervical Cancer[J].Medical Information,2022,35(15):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
[6]覃念群,刘 楷,米镜霖,等.基于生物信息学分析筛选与宫颈癌预后相关的关键基因[J].医学信息,2022,35(10):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
QIN Nian-qun,LIU Kai,MI Jing-lin,et al.Screening Key Genes Related to the Prognosis of Cervical Cancer Based on Bioinformatics Analysis[J].Medical Information,2022,35(15):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
[7]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Medical Information,2018,31(15):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[8]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Medical Information,2018,31(15):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[9]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Medical Information,2018,31(15):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
[10]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Medical Information,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
[11]见永康,吴泽俊,庄雅丽.宫颈癌筛查联合阴道镜活检防治宫颈癌前病变的价值研究[J].医学信息,2023,36(16):117.[doi:10.3969/j.issn.1006-1959.2023.16.022]
JIAN Yong-kang,WU Ze-jun,ZHUANG Ya-li.Study on the Value of Cervical Cancer Screening Combined with Colposcopy Biopsy in the Prevention and Treatment of Cervical Precancerous Lesions[J].Medical Information,2023,36(15):117.[doi:10.3969/j.issn.1006-1959.2023.16.022]